Author:
İlhan Algin Demet,Osman Erdinç Oğuz
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited disorder, with an estimated prevalence of 1 in 3000–4000 people. Seizures occur 4–7% of individuals with NF1, mostly due to associated brain tumors or cortical malformations. Seizures in NF1 are often relatively easy to control with one or more conventional antiseizure drugs; surgical resection of offending lesions is sometimes pursued. Surgery has been most successful for temporal lobe gliomas. However, if you faced the drug-resistant epilepsy you may consider the cortical malformations, tumors and hippocampal sclerosis. In this chapter, it is aimed to explain the types of seizures, EEG features and the properties of drug therapy in NF1.
Reference32 articles.
1. Kresak JL, Walsh M. Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis. J Pediatr Genet 2016;5:98-104.
2. Abramowicz A, Gos M. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Dev Period Med 2014;18:297-306.
3. Ostendorf AP, Gutmann DH, Weisenberg JL. Epilepsy in individuals with neuro- fibromatosis type 1. Epilepsia 2013;54:1810-4.
4. Santoro C, Bernardo P, Coppola A, Pugliese U, Cirillo M, Giugliano T, et al. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough? Ital J Pediatr 2018;44(41)
5. Nix JS, Blakeley J, Rodriguez FJ. An update on the central nervous system manifesta- tions of neurofibromatosis type 1. Acta Neuropathol 2020;139:625-641.